Aurobindo Upbeat On Outlook As It Moves To Close Sandoz Deal

India's Aurobindo says it is betting its $1bn purchase of Sandoz' US dermatology assets will help “really fuel growth” and that the company's biggest acquisition should be wrapped up in eight to 12 weeks.